--> Adalimumab (which is a humanized recombinant antibody to TNF) showed effectiveness in patients with moderate-to-severe Crohn's disease, but less than that of infliximab.
Parkinson's disease | Alzheimer's disease | Centers for Disease Control and Prevention | Huntington's disease | Centers for Disease Control | Biological specimen | Physical therapy | Bright's disease | Dutch elm disease | disease | Crohn's disease | Chagas disease | Biological membrane | Marine Biological Laboratory | sexually transmitted disease | Reichian therapy | Plague (disease) | International Union of Biological Sciences | Chronic obstructive pulmonary disease | Therapy? | Sexually transmitted disease | Radiation therapy | Lyme disease | inflammatory | Convention on Biological Diversity | biological pest control | Biological classification | American Art Therapy Association | therapy | Salk Institute for Biological Studies |